
Sponsor
Exeliom Biosciences
67 Rue Des Godrans, 21000 Dijon, France
About the sponsor
Crohn's disease is the central therapeutic focus, with research activity directed toward maintaining clinical response and remission in patients with mild to moderate disease.
- Inflammation control
- Gastrointestinal immune modulation
- Maintenance of symptom relief
The sponsor's clinical research activity is concentrated in gastroenterology, particularly in treatment strategies relevant to inflammatory bowel disease and mucosal immune disorders.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.
